The award acknowledges Parexel for delivering the perfect decentralized trial expertise for patrons by its capabilities, experience, and affected person recruitment and retention methods
SAN ANTONIO, Oct. 14, 2022 /PRNewswire/ — Based on its current evaluation of the worldwide decentralized scientific trials (DCT) business, Frost & Sullivan has acknowledged main world scientific analysis group (CRO) Parexel with the 2022 Global Customer Value Leadership Award. Parexel combines in-house experience, affected person and caregiver insights, and cutting-edge applied sciences to plan, operationalize, and ship DCTs for biopharmaceutical prospects worldwide whereas guaranteeing the very best ranges of affected person security. The firm affords Phase I-IV scientific trial capabilities, built-in consulting experience, and broad therapeutic experience to speed up new therapies for sufferers.
Parexel has earned a status of supporting its prospects’ path towards minimizing affected person burden whereas accumulating real-time, correct scientific trial information. It builds its DCT options by collaborating intently with a spread of stakeholders and companions to evolve alongside market wants and developments. For instance, Parexel’s Patient Innovation Center optimizes affected person recruitment methods, enhances affected person retention, and will increase affected person engagement by guaranteeing trials incorporate sufferers’ views as a lot as attainable. This Patients-first method covers three essential phases of scientific trial planning and design:
- Before each DCT examine—Identify and deal with potential obstacles that hinder participation and inclusion, together with medical/scientific, logistical, and cultural/behavioral variations
- During a DCT examine—Assist sufferers with eConsent, house nursing, direct-to-patient drug shipments, and video-monitored dosing to simplify the method
- Post-study—Promptly assist prospects with getting essential therapies into the market and facilitating early entry to medicines
“Parexel’s patient-focused strategies and approach to ensure every trial is inclusive exemplifies an authentic best practice DCT implementation,” stated Surbhi Gupta, Frost & Sullivan Best Practices Senior Industry Analyst. “Its overall patients-focused approach offers immense value to existing and new customers, solidifying its reputation in the market.”
Parexel’s clear, seamless, and frictionless method and shut relationships place it as a most popular supplier. The firm observes prospects’ ache factors attentively and leverages insights to establish and discover development alternatives.
Each 12 months, Frost & Sullivan presents this award to the corporate that demonstrates excellence in implementing methods that proactively create worth for its prospects with a concentrate on bettering the return on the funding that prospects make in its providers or merchandise. The award acknowledges the recipient’s distinctive concentrate on augmenting the worth that its prospects obtain, past merely good customer support, resulting in improved buyer retention and buyer base growth.
Frost & Sullivan Best Practices awards acknowledge corporations in varied regional and world markets for demonstrating excellent achievement and superior efficiency in management, technological innovation, customer support and strategic product improvement. Industry analysts examine market members and measure efficiency by in-depth interviews, analyses and intensive secondary analysis to establish finest practices within the business.
About Frost & Sullivan
For six a long time, Frost & Sullivan has been world-renowned for serving to traders, company leaders, and governments navigate financial modifications and establish disruptive applied sciences, Mega Trends, new business fashions, and firms to motion, leading to a steady movement of development alternatives to drive future success. Contact us: Start the dialogue.
Contact:
Lindsey Whitaker
P: 1.210.477.8457
E: [email protected]
About Parexel
One of the most important scientific analysis organizations, Parexel helps the event of revolutionary new medicines to enhance the well being of sufferers. We present providers to assist life sciences and biopharmaceutical prospects all over the place remodel scientific discoveries into new remedies. From decentralized scientific trials to regulatory consulting providers to leveraging actual world insights, our therapeutic, technical, and purposeful capability is underpinned by a deep conviction in what we do. For extra data, go to parexel.com and observe us on LinkedIn, Twitter, and Instagram.
Contacts:
Lori Preuit Dorer
+1 513 496 8121
[email protected]
Danaka Williams
+1 984 298 4207
[email protected]
Photo – https://mma.prnewswire.com/media/1919786/Parexel_Award_Logo.jpg
View authentic content material:https://www.prnewswire.co.uk/news-releases/parexel-recognized-by-frost–sullivan-with-2022-global-customer-value-leadership-award-301648494.html
